NCT03843528 2025-08-11Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell TransplantationJohns Hopkins All Children's HospitalPhase 1 Active not recruiting15 enrolled
NCT02419755 2018-03-07Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic MalignanciesSt. Jude Children's Research HospitalPhase 2 Terminated12 enrolled 10 charts
NCT00045006 2013-05-30Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed